🇺🇸 FDA
Patent

US 10266529

Salts, co-crystals, and polymorphs of an anxiolytic compound

granted A61PA61P21/02A61P25/00

Quick answer

US patent 10266529 (Salts, co-crystals, and polymorphs of an anxiolytic compound) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IRONWOOD PHARMACEUTICALS, INC.
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P21/02, A61P25/00, A61P25/04, A61P25/14